欧洲甲状腺学会/欧洲心血管介入放射学会《甲状腺癌微创治疗的临床实践指南》解读:审时与度势  

Interpretation and discussion of European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions: timing and indications

作　　者：胡欣[1] 褚晓秋[1] 陈国芳[1] 徐书杭[1] 刘超[1] Hu Xin;Chu Xiaoqiu;Chen Guofang;Xu Shuhang;Liu Chao(Department of Endocrinology,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,China)

机构地区：[1]南京中医药大学附属中西医结合医院内分泌科,南京210028

出　　处：《国际内分泌代谢杂志》2023年第3期278-282,共5页International Journal of Endocrinology and Metabolism

基　　金：江苏省重点研发计划(社会发展)(BE2020726)。

摘　　要：甲状腺癌的微创治疗现状仍颇具争议。欧洲甲状腺学会/欧洲心血管介入放射学会于2021年发布了《甲状腺癌微创治疗的临床实践指南》, 其纳入了甲状腺癌微创治疗的新近研究结果, 界定了甲状腺癌微创治疗及综合治疗的适应证, 并对原发性甲状腺癌、复发性甲状腺癌及甲状腺癌远处转移的微创治疗进行了详细阐述。本指南共有18条推荐条款, 涵盖了微创治疗的指征评估、治疗模式的选择、微创治疗的利弊与随访监测等方面, 为甲状腺癌的微创治疗提供了更为合理及规范的建议。The status of minimally invasive treatment for thyroid cancer remains controversial.European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe issued clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions in 2021,which incorporated recent findings on minimally invasive treatment of thyroid carcinoma,and the indications for minimally invasive treatment or a multimodality approach of thyroid malignancies were defined.The minimally invasive treatment in primary thyroid neoplasms,neck recurrences of thyroid carcinoma,and metastastic thyroid cancer were clarified.This guideline consists of 18 recommendations,covering the scopes of assessment of the indications,preference of treatment modalities,advantages and limitations of minimally invasive treatment,and follow-up,which provide more reasonable and standardized guidance for minimally invasive treatment of thyroid cancer.

关 键 词：甲状腺癌 甲状腺微小乳头状癌 复发性甲状腺癌 甲状腺癌远处转移 微创治疗 

分 类 号：R736.1[医药卫生—肿瘤]